Search Results - "GEROTZIAFAS, Grigoris T"
-
1
Disseminated Intravascular Coagulation: An Update on Pathogenesis, Diagnosis, and Therapeutic Strategies
Published in Clinical and Applied Thrombosis/Hemostasis (01-12-2018)“…Disseminated intravascular coagulation (DIC) is an acquired clinicobiological syndrome characterized by widespread activation of coagulation leading to fibrin…”
Get full text
Book Review Journal Article -
2
An Update on the Pathogenesis of COVID-19 and the Reportedly Rare Thrombotic Events Following Vaccination
Published in Clinical and Applied Thrombosis/Hemostasis (2021)“…Today the coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has become a global health problem…”
Get full text
Book Review Journal Article -
3
Extracellular vesicles derived from pancreatic cancer cells BXPC3 or breast cancer cells MCF7 induce a permanent procoagulant shift to endothelial cells
Published in Thrombosis research (01-03-2020)“…AbstractThe endothelium could be a potential target of cancer cell derived extracellular vesicles (CaCe-dEV). We investigated in vitro the effect of CaCe-dEV…”
Get full text
Journal Article -
4
Thrombotic and Hemorrhagic Issues Associated with Myeloproliferative Neoplasms
Published in Clinical and Applied Thrombosis/Hemostasis (2022)“…Thrombotic and hemorrhagic complications are related to a significant rate of morbidity and mortality in patients with myeloproliferative neoplasms (MPNs),…”
Get full text
Book Review Journal Article -
5
An Update on the Status of Vaccine Development for SARS-CoV-2 Including Variants. Practical Considerations for COVID-19 Special Populations
Published in Clinical and applied thrombosis/hemostasis (01-01-2022)“…The progress in the development of various vaccine platforms against SARS-CoV-2 have been rather remarkable owing to advancement in molecular and biologic…”
Get full text
Journal Article -
6
Impact of breast cancer stage, time from diagnosis and chemotherapy on plasma and cellular biomarkers of hypercoagulability
Published in BMC cancer (22-12-2014)“…In breast cancer patients routine thromboprophylaxis is not recommended but individualized risk assessment is encouraged. The incorporation of…”
Get full text
Journal Article -
7
Endothelial Cell Activation and Thrombin Generation Assessment for the Risk of Severe Early Onset Preeclampsia. the ROADMAP-EOP Study
Published in Clinical and applied thrombosis/hemostasis (01-01-2022)“…Background The ROADMAP-EOP study aimed to identify clinically relevant biomarkers of hypercoagulability for the identification of pregnant women at risk of…”
Get full text
Journal Article -
8
Position Paper on the Management of Pregnancy-Associated Superficial Venous Thrombosis. Balkan Working Group for Prevention and Treatment of Venous Thromboembolism
Published in Clinical and Applied Thrombosis/Hemostasis (01-01-2022)“…Venous thromboembolism (VTE) is a multifactorial disease that can possibly affect any part of venous circulation. The risk of VTE increases by about 2 fold in…”
Get full text
Book Review Journal Article -
9
Public Awareness on Cancer-Associated Thrombosis among the Greek Population: First Findings from the ROADMAP-CAT Awareness Study
Published in TH open : companion journal to thrombosis and haemostasis (01-04-2022)“…Abstract Background Cancer-associated thrombosis (CAT) is the second cause of mortality after cancer itself. CAT is underestimated as a health challenge among…”
Get full text
Journal Article -
10
Prospective Assessment of Biomarkers of Hypercoagulability for the Identification of Patients With Severe Coronary Artery Disease. The ROADMAP-CAD Study
Published in Clinical and applied thrombosis/hemostasis (2020)“…In patients with stable coronary artery disease (CAD) blood hypercoagulability figures among factors leading to thrombosis. Tissue factor (TF) exposure at…”
Get full text
Journal Article -
11
Evaluation of the pharmacological properties and clinical results of the synthetic pentasaccharide (fondaparinux)
Published in Thrombosis Research (2003)“…Fondaparinux (Arixtra®) is the first of a new class of selective indirect antithrombin-dependent factor Xa inhibitors, which inhibits thrombin generation…”
Get full text
Book Review Journal Article -
12
Erratum: Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI
Published in TH open : companion journal to thrombosis and haemostasis (01-10-2019)Get full text
Journal Article -
13
Impact of blood hypercoagulability on in vitro fertilization outcomes: a prospective longitudinal observational study
Published in Thrombosis journal (28-03-2017)“…Blood coagulation plays a crucial role in the blastocyst implantation process and its alteration may be related to in vitro fertilization (IVF) failure. We…”
Get full text
Journal Article -
14
Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI
Published in TH open : companion journal to thrombosis and haemostasis (01-07-2019)“…Abstract Direct oral anticoagulants (DOACs) represent an attractive alternative to low-molecular-weight heparins (LMWHs) for the long-term treatment of…”
Get full text
Journal Article -
15
The study of the thrombin generation mechanism and the effect of low molecular weight heparin as thromboprophylaxis in patients undergoing total knee and hip replacement
Published in Thrombosis research (01-12-2013)“…Abstract Introduction The recommended duration of post-operative Low-Molecular-Weight-Heparins (LMWHs) thromboprophylaxis in Total-Hip-Replacement (THR) and…”
Get full text
Journal Article -
16
The COMPASS-COVID-19-ICU Study: Identification of Factors to Predict the Risk of Intubation and Mortality in Patients with Severe COVID-19
Published in Hemato (01-03-2022)“…In some patients, SARS-CoV-2 infection induces cytokine storm, hypercoagulability and endothelial cell activation leading to worsening of COVID-19, intubation…”
Get full text
Journal Article -
17
Bacterial coinfection in critically ill COVID-19 patients with severe pneumonia
Published in Infection (01-06-2021)“…Severe 2019 novel coronavirus infectious disease (COVID-19) with pneumonia is associated with high rates of admission to the intensive care unit (ICU)…”
Get full text
Journal Article -
18
A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS–Cancer‐Associated Thrombosis Study
Published in The oncologist (Dayton, Ohio) (01-10-2017)“…Background The stratification of outpatients on chemotherapy for breast, colorectal, lung, and ovarian cancers at risk of venous thromboembolism (VTE) remains…”
Get full text
Journal Article -
19
Modelization of Blood-Borne Hypercoagulability in Myeloma: A Tissue-Factor-Bearing Microparticle-Driven Process
Published in TH open : companion journal to thrombosis and haemostasis (01-10-2019)“…Abstract Introduction Hypercoagulability is a common blood alteration in newly diagnosed chemotherapy naïve patients with multiple myeloma. The identification…”
Get full text
Journal Article -
20
Towards a standardization of thrombin generation assessment: the influence of tissue factor, platelets and phospholipids concentration on the normal values of Thrombogram-Thrombinoscope assay
Published in Thrombosis journal (26-10-2005)“…Thrombin generation assay was developed several years ago to mimic physiological coagulation mechanisms but it had important limitations…”
Get full text
Journal Article